Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Fluid Management in Emergency Department Patients
ACTRN12614001178639Phase 4Withdrawn
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of plasma-lyte and sodium chloride in None (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: Delta creatinine. Planned start Jan 2015; status: withdrawn.
02
Drugs
plasma-lytesodium chloride
Beyond the preview
Go deeper on ACTRN12614001178639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001178639.